
2.89 Delayed Data As of 3:58pm ET | ![]() Today’s Change | 2.67 Today|||52-Week Range 66.00 | -88.60% Year-to-Date |
The 3 analysts offering 12-month price forecasts for Sonnet Biotherapeutics Holdings Inc have a median target of 75.00, with a high estimate of 100.00 and a low estimate of 44.00. The median estimate represents a +2,499.65% increase from the last price of 2.89.
The current consensus among 3 polled investment analysts is to Buy stock in Sonnet Biotherapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.